Search Results - mark+yarmarkovich

1 Results

Sort By:

Optimized discovery of tumor specific antigens for neuroblastoma immunotherapy

Data-driven discovery of tumor antigens using ligandomics, proteomics, and gene expressionMarket NeedThe current standard of care for high-risk neuroblastoma is extremely costly, involving an intense regimen of chemotherapy, radiation therapy, multiple surgeries, and immunotherapy (a typical treatment regimen for high-risk neuroblastoma can be found...

Published: 6/25/2019 | Inventor(s): John Maris, Mark Yarmarkovich

Keywords(s):

Category(s): Therapeutic